Alps Advisors Inc Terns Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$4.7 - $8.55 $15,806 - $28,753
3,363 Added 8.07%
45,028 $226,000
Q2 2023

Aug 14, 2023
BUY
$7.35 - $13.29 $73,955 - $133,723
10,062 Added 31.84%
41,665 $364,000
Q1 2023

May 10, 2023
BUY
$7.91 - $12.0 $48,076 - $72,936
6,078 Added 23.81%
31,603 $374,000
Q4 2022

Feb 14, 2023
BUY
$4.62 - $10.18 $117,925 - $259,844
25,525 New
25,525 $259,000

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email